HIGH SENSITIVITY C-REACTIVE PROTEIN AND PLASMA LIPIDS IN TYPE 2DIABETIC PATIENTS IN ENUGU, NIGERIA.

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2017, Vol 4, Issue 11

Abstract

Background: Type II Diabetes is a worldwide health problem. It exerts a heavy economic burden on the society and is associated with microvascular and macrovascular complications. Objective: This study on high sensitivity C-reactive protein (hs-CRP) and plasma lipids in type II diabetic patients was carried out to have a baseline data of hs-CRP and plasma lipids in type II diabetics and its relation to glycaemic control. Methods: In this cross-sectional study 150 known type II diabetics and 100 age-matched non diabetics without inflammatory conditions were used as controls. Fasting plasma glucose, lipids and hs-CRP were assayed, Body mass index was calculated by using the Quetelet formula [weight (Kg)/height (m2)]. Values presented as mean ± 2standard deviations. Student’s t test and Chi-square tests were used to compare the means and proportion between two groups respectively. Pearson correlation was utilised in comparing the relationship between the hs-CRP and other parameters. Results: In the diabetics the following plasma parameters were significantly higher (p<0.05) than in the non-diabetic controls. In mmol/L, glucose 5.44± 1.19(4.88±1.41), TC 6.03±1.16(5.01±1.39), LDL Cholesterol 5.28±1.43(3.90±1.27), TG1.12±0.58(0.81±0.29); hs-CRP 0.12±0.10mg/dl(0.07±0.04), BMI29.04±5.72Kg/ m2(23.62±5.22) There was a significant decrease in HDL Cholesterol in diabetics than in the non-diabetic controls, 1.38±0.25mmol/L (1.47±0.38). Pearson’s Correlation Coefficient for hs-CRP and BMI is 0.119(p>0.05 and was not significant). Conclusion: Data shows that there are significant increases in the parameters measured in all the diabetic subjects except in HDL-cholesterol where there is significant reduction when compared with the control (P<0.05). There is no significant correlation between the hsC-reactive protein and BMI (P>0.05). The results concluded that total Cholesterol, triglyceride, low density lipoprotein cholesterol and hs–CRP have strong associations with type 2 diabetes mellitus, the significance of these associations was discussed.

Authors and Affiliations

Okeke Nduka

Keywords

Related Articles

EPIDEMIOLOGICAL STUDY OF CUTANEOUS LEISHMANIASIS IN DIYALA PROVINCE

Epidemiology is the study of disease occurrence in human populations. As a science, epidemiology emphasizes descriptive and analytic observation, clinical trial, behavioral intervention and the practical utility of diagn...

EFFECT OF COARTEM ON METHAEMOGLOBIN, OXYHAEMOGLOBIN AND PACKED CELL VOLUME AMONG RIVERS STATE UNIVERSITY STUDENTS IN NIGERIA

Malaria as a disease sickens and kills human through several pathological mechanisms that is understood to varying degrees. The reason for treatment is to prevent death or long-term deficits or complications from malaria...

TRANSIENT ISCHEMIC ATTACK AS A PREDICTOR OF STROKE

Transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by focal brain or retinal ischemia, with clinical symptoms typically lasting less than one hour, and without evidence of acute infarct...

REVIEW ON PRONIOSOMES AS A NOVEL CARRIER FOR NOVEL DRUG DELIVERY SYSTEM

Proniosomes are liquid crystalline compact niosome hybrids which upon hydration form niosomes. It is drug with larger physical and chemical stability and potentially scalable for commercial viability. Proniosomes overcom...

COLORIMETRIC DETECTION OF PLASMODIUM VIVAX IN PATIENT’S URINE USING MSP10 OLIGONUCLEOTIDES AND GOLD NANOPARTICLES

Background: In Sudan and elsewhere, diagnosis of malaria relies entirely on examination of blood taken from suspected individuals. In this study an attempt to examine urine for detection of P. vivax infection is carried...

Download PDF file
  • EP ID EP630384
  • DOI -
  • Views 144
  • Downloads 0

How To Cite

Okeke Nduka (2017). HIGH SENSITIVITY C-REACTIVE PROTEIN AND PLASMA LIPIDS IN TYPE 2DIABETIC PATIENTS IN ENUGU, NIGERIA.. European Journal of Biomedical and Pharmaceutical Sciences, 4(11), 96-102. https://europub.co.uk./articles/-A-630384